# Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females

> **NCT00796289** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 350 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** GnRH iontophoretic transdermal Lutrepatch
- **DRUG:** GnRH iontophoretic transdermal Lutrepatch
- **DRUG:** GnRH iontophoretic transdermal Lutrepatch
- **DRUG:** clomiphene citrate
- **DRUG:** placebo clomiphene citrate
- **DRUG:** placebo GnRH patch

## Key facts

- **NCT ID:** NCT00796289
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2015-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796289, "Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00796289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*